Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guarneri

Showing results (261-270 of 1,783) with videos related to

Pageof 179
Sort By:
Current Opinion in Oncology|October 17, 2018
Escalation and de-escalation in HER2 positive early breast cancerMaria Vittoria Dieci, Grazia Vernaci, Valentina Guarneri
Minerva Pediatrica|September 30, 2006
[Endocrine disrupters and male gonads]M P Guarneri, I Colombo, G Chiumello
International Journal of Clinical Oncology|July 11, 2019
Analysis of response-related endpoints in trials of first-line medical treatment of metastatic colorectal cancerGiuseppe A Colloca, Antonella Venturino, Domenico Guarneri
Archives of Dermatology|July 17, 2001
Off-center fold: multiple papulonodular lesions on the arm. Diagnosis: metastatic melanoma of unknown primary originS P Cannavò, M Vaccaro, B Guarneri
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|January 10, 2020
Different variables predict the outcome of patients with synchronous versus metachronous metastases of colorectal cancerG A Colloca, A Venturino, D Guarneri
Cancer Investigation|December 23, 2020
Systemic Inflammation Scores Predict the Activity of First-Line Chemotherapy in Patients with Metastatic Pancreatic AdenocarcinomaGiuseppe A Colloca, Antonella Venturino, Domenico Guarneri
Clinical Colorectal Cancer|July 29, 2019
Neutrophil-related Variables Have Different Prognostic Effect Based on Primary Tumor Location in Patients With Metastatic Colorectal Cancer Receiving ChemotherapyGiuseppe Antonio Colloca, Antonella Venturino, Domenico Guarneri
International Journal of Clinical Oncology|February 6, 2019
Early tumor shrinkage after first-line medical treatment of metastatic colorectal cancer: a meta-analysisGiuseppe A Colloca, Antonella Venturino, Domenico Guarneri
Asia-Pacific Journal of Clinical Oncology|March 5, 2020
Neutrophil count kinetics during the first cycle of chemotherapy predicts the outcome of patients with locally advanced or metastatic pancreatic cancerGiuseppe Antonio Colloca, Antonella Venturino, Domenico Guarneri
International Journal of Colorectal Disease|February 24, 2021
Leukocyte kinetics during the first cycle of chemotherapy predicts the outcome of patients with metastatic colorectal cancer and previous resection of the primary tumorGiuseppe Antonio Colloca, Antonella Venturino, Domenico Guarneri
Pageof 179

Showing results (261-270 of 1,783) with videos related to

Sort By:
Pageof 179
Current Opinion in Oncology|October 17, 2018
Escalation and de-escalation in HER2 positive early breast cancerMaria Vittoria Dieci, Grazia Vernaci, Valentina Guarneri
Minerva Pediatrica|September 30, 2006
[Endocrine disrupters and male gonads]M P Guarneri, I Colombo, G Chiumello
International Journal of Clinical Oncology|July 11, 2019
Analysis of response-related endpoints in trials of first-line medical treatment of metastatic colorectal cancerGiuseppe A Colloca, Antonella Venturino, Domenico Guarneri
Archives of Dermatology|July 17, 2001
Off-center fold: multiple papulonodular lesions on the arm. Diagnosis: metastatic melanoma of unknown primary originS P Cannavò, M Vaccaro, B Guarneri
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|January 10, 2020
Different variables predict the outcome of patients with synchronous versus metachronous metastases of colorectal cancerG A Colloca, A Venturino, D Guarneri
Cancer Investigation|December 23, 2020
Systemic Inflammation Scores Predict the Activity of First-Line Chemotherapy in Patients with Metastatic Pancreatic AdenocarcinomaGiuseppe A Colloca, Antonella Venturino, Domenico Guarneri
Clinical Colorectal Cancer|July 29, 2019
Neutrophil-related Variables Have Different Prognostic Effect Based on Primary Tumor Location in Patients With Metastatic Colorectal Cancer Receiving ChemotherapyGiuseppe Antonio Colloca, Antonella Venturino, Domenico Guarneri
International Journal of Clinical Oncology|February 6, 2019
Early tumor shrinkage after first-line medical treatment of metastatic colorectal cancer: a meta-analysisGiuseppe A Colloca, Antonella Venturino, Domenico Guarneri
Asia-Pacific Journal of Clinical Oncology|March 5, 2020
Neutrophil count kinetics during the first cycle of chemotherapy predicts the outcome of patients with locally advanced or metastatic pancreatic cancerGiuseppe Antonio Colloca, Antonella Venturino, Domenico Guarneri
International Journal of Colorectal Disease|February 24, 2021
Leukocyte kinetics during the first cycle of chemotherapy predicts the outcome of patients with metastatic colorectal cancer and previous resection of the primary tumorGiuseppe Antonio Colloca, Antonella Venturino, Domenico Guarneri
Pageof 179